IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-81-322-0792-4_15.html
   My bibliography  Save this book chapter

Acquiring Gilead Sciences as a Proposed Strategy for Merck & Co. Growth

In: Emerging Dimensions of Technology Management

Author

Listed:
  • Derek Haacker

    (Pepperdine University)

  • Cory Nolan

    (Pepperdine University)

  • Venkatachalam Seshan

    (Pepperdine University)

Abstract

Merck & Co., a global top ten pharmaceutical company with net sales of $27.4 billion and $13 billion in net income in 2009, controls 4.8 % of the United States market share and 3.39 % of the global pharmaceutical market share (Anon (2011e) Merck 10-K [Online] (Updated 11 February 2011) Available at: http://www.mergentonline.com.lib.pepperdine.edu . Accessed 11 Feb 2011). Through extensive environmental industry analysis and company assessment, the expansion of research and development through the acquisition of biotechnical research Gilead Sciences is a strategy for corporate growth. Gilead is a viable candidate for Merck possessing access to increasingly profitable biotechnology and pipeline presence in the cardiovascular and central nervous market segments. Merck can increase market share and develop new products that reinforce “building and sustaining high performance organizations in a challenging environment.”

Suggested Citation

  • Derek Haacker & Cory Nolan & Venkatachalam Seshan, 2013. "Acquiring Gilead Sciences as a Proposed Strategy for Merck & Co. Growth," Springer Books, in: K.B. Akhilesh (ed.), Emerging Dimensions of Technology Management, edition 127, pages 185-200, Springer.
    • Handle: RePEc:spr:sprchp:978-81-322-0792-4_15
    DOI: 10.1007/978-81-322-0792-4_15
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-81-322-0792-4_15. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.